tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RAPT Stock Latest News

RAPT Therapeutics: Promising Pipeline and Superior Efficacy of Lead Candidate Ozureprubart
RatingsRAPT Therapeutics: Promising Pipeline and Superior Efficacy of Lead Candidate Ozureprubart
8d ago
RAPT
Rapt Therapeutics participates in a conference call with H.C. Wainwright
PremiumThe Fly
Rapt Therapeutics participates in a conference call with H.C. Wainwright
8d ago
RAPT
RAPT Therapeutics Announces CMO Departure
PremiumCompany Announcements
RAPT Therapeutics Announces CMO Departure
14d ago
8K
RAPT
Rapt Therapeutics price target raised to $57 from $55 at JPMorgan
PremiumThe Fly
Rapt Therapeutics price target raised to $57 from $55 at JPMorgan
1M ago
RAPT
Rapt Therapeutics price target lowered to $56 from $58 at Barclays
PremiumThe Fly
Rapt Therapeutics price target lowered to $56 from $58 at Barclays
1M ago
RAPT
RAPT Therapeutics Advances with Strong Financial Backing
PremiumCompany AnnouncementsRAPT Therapeutics Advances with Strong Financial Backing
1M ago
RAPT
Rapt Therapeutics shares ‘exceptionally compelling,’ says Clear Street
Premium
The Fly
Rapt Therapeutics shares ‘exceptionally compelling,’ says Clear Street
1M ago
RAPT
Promising Clinical and Financial Developments Drive Buy Rating for RAPT Therapeutics
Premium
Ratings
Promising Clinical and Financial Developments Drive Buy Rating for RAPT Therapeutics
1M ago
RAPT
Buy Rating for RAPT Therapeutics Driven by Promising Ozureprubart Data and Strategic Growth Plans
PremiumRatings
Buy Rating for RAPT Therapeutics Driven by Promising Ozureprubart Data and Strategic Growth Plans
1M ago
RAPT
Rapt Therapeutics reports Q3 EPS (65c), consensus (85c)
PremiumThe Fly
Rapt Therapeutics reports Q3 EPS (65c), consensus (85c)
1M ago
RAPT
Rapt Therapeutics price target raised to $72 from $48 at Wells Fargo
PremiumThe Fly
Rapt Therapeutics price target raised to $72 from $48 at Wells Fargo
1M ago
RAPT
Rapt Therapeutics price target raised to $72 from $27 at H.C. Wainwright
PremiumThe Fly
Rapt Therapeutics price target raised to $72 from $27 at H.C. Wainwright
2M ago
RAPT
Clear Street positive on Rapt Therapeutics into food allergy study
PremiumThe FlyClear Street positive on Rapt Therapeutics into food allergy study
2M ago
RAPT
Rapt Therapeutics initiates prestIgE Phase 2b trial
Premium
The Fly
Rapt Therapeutics initiates prestIgE Phase 2b trial
2M ago
RAPT
Rapt Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Rapt Therapeutics initiated with a Buy at Guggenheim
2M ago
CHRO
RAPT
Rapt Therapeutics Advances Food Allergy Treatment with RPT904 Study
PremiumCompany Announcements
Rapt Therapeutics Advances Food Allergy Treatment with RPT904 Study
2M ago
RAPT
RAPT Therapeutics Announces Major Public Stock Offering
PremiumCompany Announcements
RAPT Therapeutics Announces Major Public Stock Offering
2M ago
8K
RAPT
Rapt Therapeutics 8.333M share Spot Secondary priced at $30.00
PremiumThe Fly
Rapt Therapeutics 8.333M share Spot Secondary priced at $30.00
2M ago
RAPT
Rapt Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Rapt Therapeutics announces common stock offering, no amount given
2M ago
RAPT
Rapt Therapeutics price target raised to $48 from $38 at Wells Fargo
PremiumThe FlyRapt Therapeutics price target raised to $48 from $38 at Wells Fargo
2M ago
RAPT
Rapt Therapeutics price target raised to $60 from $41 at Clear Street
Premium
The Fly
Rapt Therapeutics price target raised to $60 from $41 at Clear Street
2M ago
RAPT
RAPT Therapeutics Reports Positive Phase 2 Trial Results
Premium
Company Announcements
RAPT Therapeutics Reports Positive Phase 2 Trial Results
2M ago
8K
RAPT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >